FDANews
FDAnews Drug Daily Bulletin

Jazz Pharma Agrees to Sell Women’s Health Business

Sept. 10, 2012
The Irish drugmaker Jazz Pharmaceuticals is selling its women’s health business to specialty pharmaceutical company Meda for $95 million in cash so that it can concentrate on its core products.
Businessweek